Leon M. van Den Toorn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Leon M. van Den Toorn has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- A. Griffioen
Department of Cardiology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands
1 shared publication - A. P. C. Berendse
Dutch Sarcoidosis Patient Organisation (Sarcoidose.nl)
1 shared publication - A.R. Bijsmans1 shared publication
- Adriaan O. Kraaijeveld
Department of Cardiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
1 shared publication - Annemien E. van Den Bosch
Department of Cardiology, Cardiovascular Institute, Thorax Center, Erasmus MC, Rotterdam, The Netherlands
1 shared publication - Bram B. van der Meijs
Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam UMC location AMC, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands
1 shared publication
Latest Publications
- Open Access
- 8 August 2025
- Published by Elsevier in Thrombosis Research
- Vol. 255, 109420
Thrombectomy in high-risk pulmonary embolism – device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized controlled trial
- 8 August 2025
- Published by Elsevier in Thrombosis Research
- Vol. 255, 109420
Open AccessThrombectomy in high-risk pulmonary embolism – device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized controlled trial
- Open Access
- 10 June 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (12) , 6508
Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity
Pulmonary arterial hypertension (PAH) is rare disease that is categorized as idiopathic (IPAH) when no underlying cause can be identified. Lungs of most patients with IPAH contain increased numbers of T cells and dendritic cells (DCs), suggesting involvement of the immune system in its pathophysiology. However, our knowledge on circulating immune cells in IPAH is rather limited. We used flow cytometry to characterize peripheral blood DCs and T cells in treatment-naive IPAH patients, compared with connective-tissue disease-PAH (CTD-PAH) patients and healthy controls (HCs). At diagnosis, T-helper (Th) cells of IPAH patients were less capable of producing TNFα, IFNγ, IL-4 and IL-17 compared to HCs. IPAH patients showed a decreased frequency of Th2 cells and significantly enhanced expression of the CTLA4 checkpoint molecule in naive CD4+ T cells and both naive and memory CD8+ T cells. Frequencies and surface marker expression of circulating DCs and monocytes were essentially comparable between IPAH patients and HCs. Principal component analysis (PCA) separated IPAH patients—but not CTD-PAH patients—from HCs, based on T-cell cytokine profiles. At 1-year follow-up, the frequencies of IL-17+ production by memory CD4+ T cells were increased in IPAH patients and accompanied by increased proportions of Th17 and Tc17 cells, as well as decreased CTLA4 expression. Treatment-naive IPAH patients displayed a unique T-cell phenotype that was different from CTD-PAH patients and was characterized by reduced cytokine-producing capacity. These findings point to involvement of adaptive immune responses in IPAH, which may have an implication for the development of therapeutic interventions.
- 10 June 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (12) , 6508
Open AccessPeripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity
Pulmonary arterial hypertension (PAH) is rare disease that is categorized as idiopathic (IPAH) when no underlying cause can be identified. Lungs of most patients with IPAH contain increased numbers of T cells and dendritic cells (DCs), suggesting involvement of the immune system in its pathophysiology. However, our knowledge on circulating immune cells in IPAH is rather limited. We used flow cytometry to characterize peripheral blood DCs and T cells in treatment-naive IPAH patients, compared with connective-tissue disease-PAH (CTD-PAH) patients and healthy controls (HCs). At diagnosis, T-helper (Th) cells of IPAH patients were less capable of producing TNFα, IFNγ, IL-4 and IL-17 compared to HCs. IPAH patients showed a decreased frequency of Th2 cells and significantly enhanced expression of the CTLA4 checkpoint molecule in naive CD4+ T cells and both naive and memory CD8+ T cells. Frequencies and surface marker expression of circulating DCs and monocytes were essentially comparable between IPAH patients and HCs. Principal component analysis (PCA) separated IPAH patients—but not CTD-PAH patients—from HCs, based on T-cell cytokine profiles. At 1-year follow-up, the frequencies of IL-17+ production by memory CD4+ T cells were increased in IPAH patients and accompanied by increased proportions of Th17 and Tc17 cells, as well as decreased CTLA4 expression. Treatment-naive IPAH patients displayed a unique T-cell phenotype that was different from CTD-PAH patients and was characterized by reduced cytokine-producing capacity. These findings point to involvement of adaptive immune responses in IPAH, which may have an implication for the development of therapeutic interventions.
- 2 April 2020
- Vol. 164
[The e-cigarette: the ultimate Trojan horse].
Electronic cigarettes have rapidly attracted interest as a method to help people quit smoking, on the premise that e-cigarettes are less harmful than tobacco. However, so far studies have not provided convincing evidence that using electronic cigarettes is a better method of smoking cessation than other methods such as motivational counselling, either with or without nicotine replacement therapy. In addition, there is an alarming growth in the popularity of vaping among young people who find e-cigarettes attractive. Recent studies show the harmful effects of the ingredients of the e-cigarette fluid have resulted in acute pulmonary complications such as organizing pneumonia, asthma attacks and diffuse alveolar bleeding. The long-term effects of e-cigarettes are largely unknown, but one doesn't need to be a soothsayer to predict that the long-term damage will be significant. In conclusion, as pulmonologists, we find it necessary to give a serious warning to the Dutch population and would summarize the recommendations for vaping with one simple word - "Don't".
- 2 April 2020
- Vol. 164
[The e-cigarette: the ultimate Trojan horse].
Electronic cigarettes have rapidly attracted interest as a method to help people quit smoking, on the premise that e-cigarettes are less harmful than tobacco. However, so far studies have not provided convincing evidence that using electronic cigarettes is a better method of smoking cessation than other methods such as motivational counselling, either with or without nicotine replacement therapy. In addition, there is an alarming growth in the popularity of vaping among young people who find e-cigarettes attractive. Recent studies show the harmful effects of the ingredients of the e-cigarette fluid have resulted in acute pulmonary complications such as organizing pneumonia, asthma attacks and diffuse alveolar bleeding. The long-term effects of e-cigarettes are largely unknown, but one doesn't need to be a soothsayer to predict that the long-term damage will be significant. In conclusion, as pulmonologists, we find it necessary to give a serious warning to the Dutch population and would summarize the recommendations for vaping with one simple word - "Don't".
- Open Access
- 7 August 2018
- Published by Springer Nature in Lung
- Vol. 196 (5) , 569-575
Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners
Sarcoidosis is a chronic, multisystem disease with often a major impact on quality of life. Information on unmet needs of patients and their partners is lacking. We assessed needs and perceptions of sarcoidosis patients and their partners.
- 7 August 2018
- Published by Springer Nature in Lung
- Vol. 196 (5) , 569-575
Open AccessNeeds, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners
Sarcoidosis is a chronic, multisystem disease with often a major impact on quality of life. Information on unmet needs of patients and their partners is lacking. We assessed needs and perceptions of sarcoidosis patients and their partners.
- 1 October 2005
- Published by Elsevier in Lung Cancer
- Vol. 50 (1) , 123-127
Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter
- 1 October 2005
- Published by Elsevier in Lung Cancer
- Vol. 50 (1) , 123-127
Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter